IMARC Group, a leading market research company, has recently releases report titled Liquid BiopsyMarket: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028. The study provides a detailed analysis of the industry, including the globalliquid biopsy market trends, share, size, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How Big is the Liquid Biopsy Market?
Report Attributes Details
Market Size in 2022 US$ 1.8 Billion
Market Forecast in 2028 US$ 4.3 Billion
Growth rate (2023 to 2028) CAGR of 15.3%
Base Year of the Analysis 2022
Forecast Period 2023-2028
What is Liquid Biopsy?
Liquid biopsy is a medical procedure that does not involve any surgical incision and is a suitable alternative to surgical biopsies. It allows medical professionals to gather vital information about tumors by examining a sample of the patients blood. It helps create a tailored treatment plan by tracking changes in the tumors genetic makeup. For instance, it can detect gene mutations of the epidermal growth factor receptor (EGFR) in non-small cell lung cancer (NSCLC) patients. Since it facilitates early detection screening, helps account for tumor heterogeneity and identifies drug resistance, liquid biopsy is gaining immense traction across the globe.
Request Free Sample Copy of This Report:https://www.imarcgroup.com/liquid-biopsy-market/requestsample
What are the growth prospects and trends in the liquid biopsy industry?
The global liquid biopsy market is primarily driven by the rising number of cancer patients across the globe. Additionally, the surging awareness among individuals about advanced minimally invasive (MI) procedures in cancer diagnostics is positively influencing the market growth.
Moreover, the increasing investments in research and development (RD) activities by governments of numerous countries to encourage the launch of advanced cancer solutions has catalyzed market growth. Besides this, various technological advancements in liquid biopsy to offer better procedure workflow and output are other major growth-inducing factors.
Furthermore, the increasing usage of exosomes for clinical diagnosis in oncology to provide high accuracy and reduced procedural time is contributing to the market growth. Other factors, including rising tobacco consumption, sedentary lifestyles, and rapid expansion of the healthcare industry, are also anticipated to drive the market further.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Product and Service:
- Kits and Reagents
- Platforms and Instruments
- Services
Breakup by Circulating Biomarker:
- Circulating Tumor Cells
- Extracellular Vesicles
- Circulating Tumor DNA
- Others
Breakup by Cancer Type:
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Liver Cancer
- Others
Breakup by End User:
- Hospitals and Laboratories
- Academic and Research Centers
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
- ANGLE plc
- Biocept Inc.
- Bio-Rad Laboratories Inc
- Epigenomics AG
- Exact Sciences Corporation
- F.Hoffmann-La Roche AG
- Guardant Health Inc.
- Illumina Inc.
- MDxHealth SA
- Menarini Silicon Biosystems
- QIAGEN N.V.
- Thermo Fisher Scientific Inc.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Groups information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
